WHO recommendations: drug treatment for severe hypertension in pregnancy
17 December 2018
| Guideline
Overview
The primary audience of these recommendations includes healthcare providers who are responsible for developing national and local health protocols (particularly those related to hypertensive disorders of pregnancy) and those directly providing care to pregnant women and their newborns, including midwives, nurses, general medical practitioners, obstetricians, managers of maternal and child health programmes, and relevant staff in ministries of health, in all settings.
WHO Team
Guidelines Review Committee,
Sexual and Reproductive Health and Research (SRH)
Number of pages
75
Reference numbers
ISBN: 978 92 4 155043 7